Free Trial

TC Biopharm (TCBP) Insider Trading & Ownership

TC Biopharm logo
$0.66 +0.00 (+0.15%)
(As of 12/20/2024 05:45 PM ET)

TC Biopharm (NASDAQ:TCBP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.44%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$23,000.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get TCBP Insider Trade Alerts

Want to know when executives and insiders are buying or selling TC Biopharm stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TCBP Insider Buying and Selling by Quarter

TC Biopharm Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/24/2022Kenneth Edward RandallMajor ShareholderBuy10$2,300.00$23,000.00  
(Data available from 1/1/2013 forward)

TCBP Insider Trading Activity - Frequently Asked Questions

The list of insiders at TC Biopharm includes Kenneth Edward Randall. Learn more on insiders at TCBP.

15.44% of TC Biopharm stock is owned by insiders. Learn more on TCBP's insider holdings.

TC Biopharm Key Executives

  • Mr. Bryan Leland Kobel (Age 45)
    CEO & Director
    Compensation: $544.56k
  • Mr. Martin Edward Thorp (Age 72)
    CFO & Director
    Compensation: $410.52k
  • Mr. Christopher Camarra
    Executive Vice President of Communications
  • Dr. Lauren Bor Ph.D.
    Head of Commercial Development Division


This page (NASDAQ:TCBP) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners